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ABSTRACT PAGE 
Endocrine disrupting chemicals (EDCs) are a pervasive threat to the health of 
both human and wildlife populations. EDCs bind to hormone receptors and mimic 
or block their action, causing disrupted growth, metabolism and reproduction. 
Fertility affected by EDCs might be compensated if some individuals are 
genetically resistant. Genetic resistance in a variable population might cause 
hormonal feedback pathways to be more resilient to disruption. The effects of 
EDCs on fertility will be studied using a naturally variable population. A wild 
population of neonatal male mice, Peromyscus leucopus, was treated with 
testosterone propionate during a critical developmental period.  Genetic variation 
was measured by collecting testis and seminal vesicle mass. These results were 
used to determine the potential change in fertility of the mice. Results indicate 
that there is no difference detected in individuals in their response to EDCs, 
providing no evidence for an inherited difference between selection lines to these 
two chemicals. This suggests that heritable variation in response to short 
photoperiod in this population does not necessarily cause variation in fertility in 
response to other environmental variables, such as EDCs.  
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Background  
Part I. Endocrine disruptors  
Endocrine disruptors, both man-made and naturally occurring, are found in 
nearly all environments. These compounds can have widespread health impacts 
in human and animal populations (Diamanti-Kandarakis et al. 2009). Exactly how 
pervasive and detrimental these compounds are is the subject of studies 
focusing on obesity, cognitive development, cancer, and reproductive problems 
(reviewed by Vandenberg et al. 2013). Most studies focus on exposure in either 
prenatal or neonatal individuals, or adults (Jones, Shimell, and Watson 2011). 
This study includes tests at both age classes, assessing effects of potential 
endocrine disruptors on fertility in a naturally variable adult population of white-
footed mice, Peromyscus leucopus.  
Endocrine disruptors that include phytoestrogens, polychlorinated 
biphenyls (PCBs), Di(2-ethylhexyl) phthalate (DEHP), 
dichlorodiphenyltrichloroethane (DDT), bisphenol-A (BPA), and various other 
pesticides and herbicides have been shown to cause a wide variety of 
reproductive issues, often in a sex-specific manner. The herbicide Atrazine has 
been shown to completely feminize adult male frogs (Xenopus laevus), producing 
fertile females (Hayes et al. 2010). Exposure to Atrazine could lead to a decline 
in the number of frogs within a particular population, which could ramify to affect 
other trophic levels in the frogs’ habitat. A 1976 study on ringed seals in the 
Baltic Sea found dramatic effects on reproductive health following exposure to 
PCBs (Helle, Olsson, and Jensen 1976). Exposed female seals had pathological 
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uterine changes that caused reproductive failure and a subsequent population 
decline. When compared to the control population, PCB exposure was found to 
be the only significant difference. Phytoestrogens, present in soybeans, flax, 
licorice, thyme and hops are commonly consumed by wild herbivores, and 
humans (Hughes 1988). These compounds can act as both estrogenic and 
antiestrogenic compounds, causing both deleterious and therapeutic effects 
(Brzezinski and Debi 1999). They act as weak estrogens or antiestrogens by 
interfering with the luteinizing hormone (LH) feedback loop in the hypothalamic-
pituitary-ovary axis in females (Woclawek-Potocka et al. 2013). Domestic 
animals, such as sheep and cows, that have been fed a highly estrogenic diet 
(e.g. clover) have been shown to have induced temporary or permanent infertility 
(Adams 1995). Behavioral effects of phytoestrogens have been detected in red 
colobus monkeys, in which increased fecal estrogen and cortisol levels have 
been linked to increased aggression and copulation (Wasserman et al. 2012).  
The wide range of activity of phytoestrogens may be due, in part, to 
variation in individual sensitivity at the level of estrogen receptor, cofactor, 
response element or ligand (Krishnan, Heath, and Bryant 2000). Individual 
sensitivity may cause differences in how the molecules found in these plants 
target specific tissues and trigger the transcription of disruptive gene products or 
alter enzyme function. I have found no studies on individual variation in response 
to phytoestrogens.  
Bisphenol-A (BPA) is a pervasive estrogen disruptor found in plastic 
bottles, dental sealants, receipts and canned food. Figure 1 highlights in blue the 
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portions of BPA and estradiol that interacts with estrogen-related receptors. BPA 
has a high affinity for the nuclear receptor Estrogen-related-receptor gamma  
(ERR-γ) and a relatively low affinity for estrogen receptor alpha (ER-αand 
estrogen receptor beta (ER-β) [(Blair et al. 2000). ERR-γ is associated with 
regulation of transcription of estrogen sensitive genes (Ariazi, Clark, and Mertz 
2002). BPA has been shown to block estrogen at low doses and amplify estrogen 
action at high doses, although the exact mechanism for estrogen disruption is not 
completely understood (McCaffrey et al. 2013). 
BPA may act as an endocrine disruptor for fertility via different pathways. 
Studies in humans have shown that BPA inhibits testis development and 
decreases sperm production, contributes to underdevelopment of the brain and 
kidneys in embryos and fetuses, and is associated with miscarriages (Hunt et al. 
2009). Gestational exposure of BPA on murine (mouse) models has caused 
increased ovarian weights and higher incidence of oocyte damage, as well as a 
lower weight of testes and seminal vesicles (Wolstenholme, Rissman, and 
Connelly 2011). Further research is needed to assess the critical doses and 
exact mechanisms through with BPA acts on the body.  
Part II. Heritable variation in humans and animals 
 The hypothalamic-pituitary-gonadal (HPG) axis is made up of 
gonadotropin releasing hormone (GnRH) neurons releasing GnRH, the pituitary 
releasing luteinizing hormone (LH) and follicle stimulating hormone (FSH), and 
the gonads producing estrogen and testosterone (Rivier and Rivest 1991). In 
addition to GnRH neurons, kisspeptin neurons have steroid receptors that 
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receive input from circulating hormone levels (or hormone mimics) to alter GnRH 
secretion (Han et al. 2005). GnRH cells are also controlled by estrogens that can 
act directly via membrane receptors or ER- receptors (Clarke 2011). If there are 
sustained high levels of sex steroids in the body, a negative feedback is exerted 
on the GnRH pathway (Handa et al. 1994). These pathways give a possible 
explanation for the mechanistic action of BPA in the male mouse. Because BPA 
is an estrogen mimic that may act as an agonist or an antagonist, it may give a 
dose-dependent positive or negative feedback signal to GnRH neurons.  
Photoperiod regulation of fertility is controlled by the interaction between 
melatonin and the hypothalamic-pituitary-gonadal (HPG) axis (Prendergast, 
Kriegsfeld, and Nelson 2001; Paul D. Heideman and Pittman 2009). Melatonin is 
responsible, among other things, for regulating circadian rhythms in response to 
light cycles (Altun and Ugur-Altun 2007). Female hamsters that were deprived of 
light had decreased levels of luteinizing hormone and prolactin in the pituitary 
gland and were infertile (Reiter, Rudeen, and Vaughan 1976). Administration of 
melatonin was enough to restore fertility in the blinded hamsters. Melatonin acts 
on the HPG axis by binding to gonadotropin inhibitory hormone receptors to 
inhibit gonadal development and maintenance (Chowdhury et al. 2010). 
Endocrine disrupting chemicals have a broad range of mechanisms of action that 
may or may not overlap with photoperiod regulation mechanisms (Fig 2a). 
How a mouse responds to BPA can also vary between populations and 
individuals within populations. Typical populations are expected to have some 
degree of naturally occurring variation in fertility (Heideman et al. 2010). It may 
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be important to take into account heritable variation among individuals in a group 
when studying the effect of BPA on fertility. Previous toxicology studies have 
typically used single strains of laboratory animals (Festing 2010), but a recent 
study on the effects of lead found that different strains of mice had a wide variety 
of responses to exposure (Schneider et al. 2014). These differences were 
caused by genetic diversity among the strains, leading to the conclusion that 
using a single strain of mice is not sufficient to determine the risk of a compound 
(Schneider et al. 2014). Instead, a population with natural variation in 
neuroendocrine regulation of fertility may give a more accurate picture of the 
effects of toxins and endogenous hormones on the reproductive system. 
Fertility can be affected by individual variation working in concert with 
external, inhibiting factors (fig 2a). Figure 2b shows an average mouse with an 
average number of GnRH neurons under ideal conditions of food, light, and 
disease/parasite load (fig 2b). With nothing inhibiting the release of GnRH, it 
reaches threshold and delivers the adequate frequency and amplitude needed 
for fertility. That same mouse under moderately inhibitory conditions (fig 2c) will 
have a decreased level of GnRH secreted. In this model, the reduction is not 
enough to impact fertility. Only the combination of external factors and a genetic 
reduction in the number of GnRH neurons (fig 2d) will have sufficient impact on 
GnRH pulsatile release to cause the amplitude and/or frequency to be too low, 
and, according to our model, cause infertility. Thus, interactions that cause 
infertility may be missed by tests of single factors. 
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Our model P. leucopus 
This study of the effects BPA on fertility used the naturally reproductively 
variable white-footed mouse (Peromyscus leucopus) (Heideman et al. 1999) as a 
model. Several species of Peromyscus are found across North America, with 
each population having varying seasonal breeding patterns (Heideman and 
Bronson 1991). The Peromyscus leucopus used in this study were selection lines 
from a wild-source population caught in a forest on the campus of The College of 
William and Mary in 1995 (Heideman et al. 1999). The offspring of wild-caught 
mice were raised in short –day photoperiods (L8:D16) and, at the age of 70 days, 
the reproductive status of males and females was determined with testis length 
and width and, in females, ovarian and uterine diameter. Mice that were 
classified responsive (R) had reproductive organs that were less than half the 
size of the nonresponsive (NR) mice during the short-day photoperiods. R males 
were bred with R females and NR males were bred with NR females for multiple 
generations to create two selection lines within the colony (for more details see 
Heideman and Pittman, 2009). 
Because the effects of BPA in a human population are a major public 
health concern, a vertebrate mammalian model is preferable as a study system. 
While there are limitations that arise when using a mouse model due to 
physiologic differences between mice and humans, the availability of wild 
populations and ease of husbandry make these models useful to understand 
some of the mechanisms underlying the effect of endocrine disruptors on fertility. 
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Objectives Experiment 1 - BPA in Adult, Genetically Variable Males 
 To better understand the effects of endocrine disruptors on fertility, BPA 
was studied in vivo. Because BPA mimics estrogen and high levels of estrogen 
provide a negative feedback control on GnRH, I hypothesized that the GnRH 
feedback mechanism should be disrupted at high doses of BPA. This feedback 
loop inhibits release of luteinizing hormone, which is required for 
spermatogenesis. After the BPA dosing period, counts of immunoreactive (IR) 
gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus of our 
model, Peromyscus leucopus can test one prediction from this hypothesis. If a 
lower number of GnRH neurons is counted in dosed mice, it could mean that 
either there are fewer active neurons or there are more recently fired neurons 
depleted in GnRH. A pilot study by Dr. Julian Pittman showed lower levels of 
GnRH immunoreactivity in dosed NR mice. In this experiment, I compared the 
dosage groups to determine relative differences in neurons.  
The two hypotheses are as follows: Hypothesis 1: Individuals that have 
genetically greater sensitivity to inhibition in SD have an HPG that is less resilient 
to environmental perturbation (i.e. endocrine disruptors). If so, then I predict the 
NR and R selection lines may differ in changes to the number of IR-GnRH 
neurons when dosed with BPA. Alternative hypothesis: In our selection lines that 
have genetically different sensitivity to inhibition in SD, that sensitivity is specific 
to inputs (photoperiod). Other environmental inputs will have effects independent 
from the effects of SD. If so, then I predict the NR and R selection lines will not 
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differ in the number of IR-GnRH neurons in response to BPA. Because variation 
exists in all populations of animals, I used one selection line of P. leucopus that 
has shown to be reproductively responsive to changes in photoperiod (R line) 
and compare those subjects to our nonresponsive line (NR line).  
 
Methods Experiment 1 - BPA in Adult Males 
 To test the effects of BPA on fertility, mice from both selection lines of 
Peromyscus leucopus were orally dosed with BPA on cereal. Dosing with cereal 
decreases stress on the test subjects and researchers and replicates the major 
known method of exposure to BPA in humans. A study size of 7 mice per 
treatment group in each line, using males aged 70 +/- 14 days, were dosed via 
six pieces Froot LoopsTM cereal at 4pm daily, in addition to ad lib food and water. 
This treatment was based on a pilot study run in the summer of 2014 assessing 
whether the mice would eat the dosed cereal. Three dosage treatments, 0mg/L, 
50mg/L and 250mg/L, were fed to mice for a period of 21 days. The 50mg/L 
dosage is based upon previous toxicology studies in laboratory mice that 
determined the minimal level of toxic exposure to elicit a response (Pottenger et 
al. 2000). The 250mg/L dosage is approximately ¼ the dose of BPA the mice will 
tolerate before exhibiting gross symptoms of pathology (Takahashi and Oishi 
2000). 
After the dosing period of 21 days, the mice were sacrificed using 
Isoflurane for anesthesia and euthanasia. Lauren Canestrini, a senior honors 
thesis candidate, performed a terminal retro-orbital bleed under isoflurane 
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anesthesia (30%induction, 2% maintenance) to collect blood for a luteinizing 
hormone (LH) assay. Post-euthanasia, weights on testes and seminal vesicles 
were collected. Luteinizing hormone levels were measured at the University of 
Virginia School of Medicine using an ELISA assay. For details, see Heideman, et 
al. (2010). 
In order to collect the brain for neuron counting, the mice were maintained 
under isoflurane anesthetic and perfused with Zamboni’s fixative following an 
established perfusion protocol (Gage, Kipke, and Shain 2012). Brains were left 
for 24 hours in Zamboni’s fixative, followed by 24 hours in 15% sucrose solution, 
and finally stored in a 30% sucrose solution at -5 degrees Celsius for up to 3 
months.  The fixed brains were cryosectioned and every fourth slice was stained 
for GnRH neurons using the ICC protocol described by Avigdor, et al (2005). 
Counts of IR-GnRH neurons were by Emily van den Blink and Gabrielle Smith 
following protocols for accurate and consistent counting of neurons (Avigdor, 
Sullivan, and Heideman 2005). Briefly, counts were made in each mouse from 
four sections that typically have the highest abundance of GnRH neurons 
(Heideman et al. 2007), with a subset recounted blind by another individual as a 
check for accuracy and consistency.  
Results Experiment 1 – BPA in Adult Males 
There were no significant differences in the plasma level of LH between the 
responsive and nonresponsive lines (F = 2.6292, P > 0.05) or between dosages 
(F = 1.5114, P > 0.05) (Fig. 3) N = 7/treatment group. Testes mass was collected 
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post-mortem. There was a significant difference in testes mass between the 
responsive and nonresponsive lines (F = 49.0893, P < 0.05), but no difference 
between dosages (F = 3.4206, P > 0.05), nor was there an interaction between 
line and dose (F = 0.3286, P > 0.05) (Fig. 4). Mass of the seminal vesicles was 
collected post-mortem and weighed after stripping the seminal vesicles of fluid. 
There was a significant difference between the responsive and nonresponsive 
lines (F = 27.1941, P < 0.05), but no difference between dosages (F = 1.4513, P 
> 0.05), nor interaction between line crossed with dose (F = 0.7620, P > 0.05) 
(Fig. 5) N = 7/treatment group. IR-GnRH neuron counts showed no significant 
difference between lines (F = 0.1960, P > 0.05), between doses (F = 1.1114, P > 
0.05) or between line crossed with dose (F = 0.0899, P > 0.05) (Fig 6) N = 
7/treatment group. 
 A BPA sandwich ELISA (MyBioSource Mouse Bisphenol A ELISA Kit, 
Catalog # MBS2600653; detection range 3.12 – 200 ng/ml of BPA) was 
performed after the trial to determine how much BPA was in the serum 24 hours 
after the dosing. No detectable BPA was found after 20-24 hours. 
Discussion Experiment 1 – BPA in Adult Males 
 Overall, the results of the BPA dosing experiment showed no measured 
effects. We expected in a short-day photoperiod that the responsive line, 
compared to the nonresponsive line, would have significantly lower levels of LH 
(Avigdor, Sullivan, and Heideman 2005). LH can be used as a proxy for 
circulating testosterone levels because there is a proven relationship between 
levels of circulating testosterone and frequency of LH pulses (Coquelin and 
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Desjardins 1982). Instead, there was no difference in LH levels due to line or 
dose (Fig. 3). This may be due to a small sample size combined with substantial 
individual variation in LH pulses. Testes and seminal vesicle mass were shown to 
have a significant difference between the responsive and nonresponsive lines 
(Figs. 4 & 5), which confirms the difference in photoperiod sensitivity between the 
lines (Heideman et al. 1999).  
There was no significant effect based on dose of BPA (Figs. 3-6). One 
possibility is poor absorption of dietary BPA. The assay performed to test the 
amount of BPA in the blood after 20-24 hours showed undetectable BPA. While it 
is possible that nearly all absorbed BPA had been cleared, this is unlikely due to 
longer clearance rates reported in similar studies (Takahashi and Oishi 2000). 
Based on all of these results, we can neither support nor reject our hypothesis: 
that individuals that have genetically greater sensitivity to inhibition in SD have an 
HPG that is less resilient to environmental perturbation. 
 Route of administration may play an important role in the outcome of BPA 
studies. Previous studies looking at the effects of BPA have traditionally used 
gavage or injection (intraperitoneal or subcutaneous) to administer BPA. When 
these traditional routes of administration were compared in adult female rats, oral 
gavage showed a much lower bioavailability of BPA compared to either type of 
injection(Pottenger et al. 2000). A multi-generational dietary dosing study using 
similar concentrations of BPA found no change in the structure or function of 
reproductive organs in rats; this study concluded that BPA was not a 
reproductive toxicant in this context (Tyl et al. 2002). This is important because 
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the primary method of human exposure to BPA is through food and beverage 
contamination (Vandenberg et al. 2007). The main difference between animal 
studies and observational human studies seems to be that animals are 
commonly exposed in a single, high dose by injection or gavage, while humans 
may be subjected to a persistent, low dose via ingestion.  
 Although there is a dearth of studies looking at long-term, low dose 
administration of BPA in adult animals, there are several studies that examine 
the long-term effects of BPA exposure during critical developmental periods in 
neonatal test subjects (Pottenger et al. 2000). Mice and rats that had been dosed 
1-5 days after birth had significant changes in the adult reproductive tract 
(Newbold, Jefferson, and Padilla-Banks 2007). It is important to note that in 
studies of neonates, there was no difference between plasma concentration of 
BPA when administered by subcutaneous injection or oral gavage (Taylor, 
Welshons, and vom Saal 2008). Neonatal exposure of BPA in both females 
(Newbold, Jefferson, and Padilla-Banks 2007) and males (Salian, Doshi, and 
Vanage 2009) has been linked to decreased fertility. Studies focusing on prenatal 
and neonatal exposure to toxins may prove to be more relevant to human health 
than studies of adults. 
 In this study, the protocol of a 21-day dietary dosing regime of BPA may 
match potential exposure of humans. Based on previous dosing studies, we 
predicted a decrease in male fertility in both the responsive and nonresponsive 
lines (Al-Hiyasat, Darmani, and Elbetieha 2002).  Not only was there no 
difference between the two lines when dose was taken into account, there was 
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no difference between the control vehicle and two doses of BPA (Figs. 3-6). 
Based on this, as well as the BPA assay demonstrating no detectable BPA after 
20-24 hours in blood plasma, we cannot be certain that we tested our hypothesis. 
We cannot conclude that we have evidence for or against the hypothesis that 
individuals that have genetically greater sensitivity to inhibition in SD have an 
HPG that is less resilient to environmental perturbation 
 Future studies on BPA and fertility are needed to reach clear conclusions 
of the effects of BPA exposure on genetically variable populations. New 
experiments will need to tease out method of administration, dose, duration of 
dose, and sex and life stage of test animal. It is likely that prenatal and neonatal 
exposures have the biggest impact on fertility. Tests using exposure during 
development may be able to show a difference between a responsive mouse and 
a nonresponsive mouse in terms of their sensitivity to an environmental stressor. 
Objectives Experiment 2 – Testosterone in Neonatal Males 
 Prenatal or neonatal exposure to endocrine disrupting events can cause 
long-lasting physiological and behavioral effects (Jones, Shimell, and Watson 
2011).  Previous toxicology studies have shown that dosing during key 
developmental time points of neonatal brain development causes irreversible 
neurotoxic effects (Viberg et al. 2003). To study developmental exposure, in this 
experiment testosterone propionate (TP) was used as a model chemical to 
represent synthetic androgens. Studies in rats have shown that TP enhances 
short-day induced inhibition of testicular growth (Heideman, Deibler, and York 
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1998).  
Here, I tested the hypothesis that our selection lines (responsive and 
nonresponsive) differ in the sensitivity of their HPG axis to endocrine disruption. 
If the hypothesis is correct, then I predict that our responsive line will be less 
resilient to neonatal exposure of an endocrine disruptor than our nonresponsive 
line.  
Methods Experiment 2 – TP in Neonatal Males in Long Photoperiod  
 To test the effects of testosterone propionate (TP; Sigma Aldrich) on 
neonatal development, male pups aged 3 +/- 1 days received one subcutaneous 
injection of TP. Only one injection should be necessary because TP has a half-
life of 4 days, compared to 100 minutes for testosterone. The dosage, 0.1mg of 
TP dissolved in 0.05 ml of corn oil, was based on previous studies on cane mice 
and F344 rats (Bronson and Heideman 1992; Heideman, Deibler, and York 
1998). Neonatal rats received a dose of 0.1mg of TP in 0.1ml of corn oil (Paul D. 
Heideman, Deibler, and York 1998) and cane mice received a dose of 0.5mg of 
TP in 0.05ml of corn oil (Bronson and Heideman 1992). These doses were found 
to have an effect on photoperiod sensitivity in rats (Heideman, Deibler, and York 
1998), but not in cane mice, which are not photoperiodically sensitive (Bronson 
and Heideman 1992). P. leucopus pups average around 25-50% the mass of 
neonatal F344 rats, and the dosage was adjusted to match differences in body 
weight.  
 All males in separate control litters were injected with 0.05ml corn oil 
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vehicle using the same method as the experimental pups. This resulted in a total 
of four treatment groups (NR-Control, NR-TP, R-Control, R-TP). Pups were 
returned to their mother following injection and weaned around 21 days. Mice 
were born and raised in a long-day photoperiod (16h light, 8 hour dark). At 70 
days +/- 3 days the mice were euthanized using an overdose of isoflurane and 
testes and seminal vesicle masses were collected. 4-8 litters per treatment 
group, with 6-8 mice total pups per treatment group, were collected.  
Results Experiment 2 – TP in Neonatal Males in Long Photoperiod 
 Testes mass at day 70 +/- 3 days was measured immediately after 
euthanasia (Fig. 7; N = 3-4 litters/treatment group). There was a significant 
difference between the responsive and nonresponsive lines (F = 49.2849, P < 
0.05). There was also a significant difference between the control dose and the 
TP treatment (F = 6.7214, P < 0.05), but no significant effect of line interacting 
with treatment.  
 Similar results were found for stripped (fluid removed) seminal vesicle 
mass (Fig 8; N = 3-4 litters/treatment group). There was a significant difference 
between lines (F = 22.3026, P < 0.05) and between doses (F = 7.1864, P < 
0.05), but no significant effect of line crossed with dose (F = 2.5615, P > 0.05).  
Methods Experiment 2a – TP in Neonatal Males in Short Photoperiod 
 The methods in experiment 2 were used in an experiment on mice raised 
in a short-day photoperiod (8 hour light, 16h dark). TP was dissolved in corn oil 
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(0.1mg/0.05ml) in a heat block at 40 degrees Celsius, a TP preparation that was 
different from experiment 2, as the mixture was vortexed 6-7 times, but not left on 
a shaker overnight. This experiment was conducted to test if the administration of 
an exogenous hormone (TP) compounds the inhibitory effects of short 
photoperiod on fertility in one or both strains. 
Results Experiment 2a - TP in Neonatal Males in Short Photoperiod 
Testes mass at day 70 +/- 3 days was measured immediately after euthanasia 
(Fig. 9; N = 7-8 litters/treatment group). There was a significant difference 
between the responsive and nonresponsive lines (F = 48.4095, P < 0.05). There 
was no significant difference between the control dose and the TP treatment (F = 
3.0860, P > 0.05) and no significant difference for line and treatment (F = 0.1521, 
P > 0.05).  
 Similar results were found in the stripped (fluid removed) seminal vesicle 
mass (Fig. 10; N = 7-8 litters/treatment group). There was a significant difference 
between lines (F = 16.2502, P < 0.05), but not between doses (F = 0.0169, P > 
0.05) or in line and dose (F = 0.0305, P > 0.05).  
Methods Experiment 2b – Higher Dose TP in Neonatal Males in Short 
Photoperiods 
The same methods from experiments 2 and 2a were used on mice raised in a 
short-day photoperiod (8h light, 16h dark) with double the dose of testosterone 
propionate (0.2mg TP/0.05ml corn oil). Powdered crystalline TP was dissolved in 
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10 microliters of 100% ethanol and mixed with the corn oil. This solution was 
placed on a shaker at room temperature (21 degrees Celsius) overnight to 
dissolve. As in experiment 2a, this study was used to test whether a higher dose 
of an exogenous hormone (TP) compounds the effects of photoperiod on fertility. 
Results Experiment 2b - Higher Dose TP in Neonatal Males in Short 
Photoperiods 
Testes mass at day 70 +/- 3 days was measured immediately after euthanasia 
(Fig. 11; N = 6-8 litters/treatment group). There was a significant difference 
between the responsive and nonresponsive lines (F = 77.3077, P < 0.05). There 
was no significant effect of TP treatment (F = 2.3252, P > 0.05) or of TP crossed 
with line (F = 0.0566, P > 0.05).  
 Similar results were found for stripped (fluid removed) seminal vesicle 
mass (Fig 12; N = 6-8 litters/treatment group). There was a significant difference 
between the responsive and nonresponsive lines (F = 24.9924 P < 0.05), but no 
difference between dose (F =0.0643, P < 0.05) or line crossed with TP (F = 
0.0051, P < 0.05). 
Discussion Experiment 2, 2a, 2b – TP in Neonatal Males 
 Experiment 2, which looked at the effect of TP under a long-day 
photoperiod, demonstrated the efficacy of TP at suppressing fertility in both the 
responsive and nonresponsive lines. There was a significant difference in testes 
and seminal vesicle weight between the responsive and nonresponsive lines, 
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confirming the variation between selection lines. There was also a difference 
between the control dose of the corn oil vehicle and the dose of 0.1mg TP in 
0.05ml corn oil. There was no effect on selection line crossed with dose, 
suggesting that our hypothesis that the responsive line would be more sensitive 
to suppression by TP than the nonresponsive line, is not supported.  
 Experiment 2a, which looked at the effect of TP under a short-day 
photoperiod, showed only a difference between the responsive and 
nonresponsive lines. There was no difference between the control dose and the 
TP dose, nor was there a difference in line crossed with dose. These results 
suggest that our hypothesis is not supported, but the lack of response in TP 
dosed animals might be due to one of two factors. The first explanation is that the 
suppressive effect of short photoperiod is strong enough to override any 
additional suppressive effect of an endogenous hormone like TP. The second 
could be that because of an unintended change in the TP dose preparation 
protocol, the TP was not adequately dissolved in solution and the mice never 
received the dose. To assess the second possibility, we conducted experiment 
2b, and even with the higher dose, TP did not enhance reproductive inhibition 
due to short photoperiod. This is consistent with our alternative hypothesis,that 
the selection lines differ genetically in sensitivity to short photoperiod, but not in 
sensitivity to neonatal treatment with TP. 
  
Methods Experiment 2c – TP Dosing Control 
This experiment was used as a control to test for pharmacological effects of the 
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aliquots of testosterone propionate for experiments 2a and 2b. Male mice, born 
and raised in SD photoperiod, were injected twice at age 25 +/- 3 days and age 
30 +/- 3 days with aliquot 2a, 2b, or corn oil. 5 mice from each treatment group 
were injected with the original dose (0.1mg TP/0.05ml corn oil for 2a and 0.2mg 
TP/0.05ml corn oil for 2b) and another 5 mice per treatment group were injected 
with 0.5mg/0.25ml (2a) and 1mg/0.25ml (2b) in order to create a dose response 
curve. Mice were euthanized at day 38 +/- 3 days using an overdose of 
isoflurane. Testes and seminal vesicle mass were collected.  
Results Experiment 2c – TP Dosing Control  
Testes mass at day 38 +/- 3 days was measured immediately after euthanasia 
(Fig. 14; N = 7-15/treatment group), F 3.155= P > 0.05. There was a significant 
difference between the oil treatment and (2b) TP. There was no significant 
difference between (2a) TP and (2b) TP and no significant difference between 
(2a) TP and oil 
Seminal vesicle mass at day 38 +/- 3 days was measured immediately after 
euthanasia (Fig. 13; N = 7-15 litters/treatment group), F = 5.5186 P < 0.05. There 
was a significant difference between the responsive and nonresponsive lines. 
There was no significant effect of dose or of dose crossed with line. 
Discussion Experiment 2c – TP Dosing Control 
The results of the testosterone propionate (TP) dosing control experiment 
suggest that the original dose used in experiment 2a was not an effective dose of 
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TP. Most significantly, there was no difference in testes or seminal vesicle mass 
between the oil treatment and the original dose of TP. This suggests that the 
original dose of TP was ineffective, either due to the amount of TP in the dose 
(0.1mg/ml) or due to improper mixing techniques.  
The results of doses of the solution of TP used in experiment 2b 
(0.2mg/ml) were significantly different from results from the oil treatment. This 
result validates the effectiveness of the 0.2mg/ml dose and confirms that the 
results in experiment 2b involved a response to a pharmacologically relevant 
treatment with TP.  
  
Objectives: Experiment 3 – Estradiol Benzoate in Neonatal Females 
 Developmental exposure to EDCs may affect female animals differently 
due to differences in physiology and timing of development. Alpha-fetoprotein in 
female mammals binds estrogen and prevents exposure of the developing brain 
to estrogen. Without this protein, estrogens masculinize and defeminize the 
female brain. A large dose of an exogenous estrogenic compound may saturate 
alpha-fetoproteins and allow these chemicals to reach the developing 
brain(Patisaul and Polston 2008). These brain changes can result in 
inappropriate mating behavior that ultimately decreases the fitness of the 
affected female. To study this, P. leucopus females were dosed with estradiol 
benzoate (EB) during the neonatal period. In mice, females dosed with EB at 3 
days old exhibited increased aggressiveness as adults (Bronson and Desjardins 
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1968).  
 
Methods Experiment 3 – Estradiol Benzoate in Neonatal Females 
3 day old female Peromyscus leucopus were injected subcutaneously with 
0.4mg estradiol benzoate in 0.05ml corn oil (Bronson and Desjardins 1968). 
Control females received a s.c. injection of 0.05ml corn oil alone. All mice were 
raised under LD conditions with unlimited access to food.  
At age 50 days, females were paired with males that had been proven to 
be successful breeders. Mice were paired for five nights. The morning after each 
night, females were checked by vaginal lavage with saline for presence or 
absence of motile spermatozoa. After the five nights, females were sacrificed 
using isoflurane and ovary and uterine tissue was collected and weighed. 
 
Results and Discussion Experiment 3 – Estradiol Benzoate in Neonatal 
Females 
There were significant differences found in the uterine weights of female 
P. leucopus based on line (responsive or nonresponsive) (F = 10.0910, P < 
0.05), but not based on dose of estradiol benzoate (0.4 mg/0.05ml corn oil or 0 
mg/0.05ml corn oil) (F = 0.4141, P > 0.05). The same results were obtained for 
ovarian weights (F = 2.7471, P > 0.05; F = 0.3081, P > 0.05). We had predicted a 
significant reduction in fertility in females from the responsive line dosed with 
0.4mg EB, a smaller reduction in fertility in females from the responsive line 
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dosed with a control and the non-responsive line dosed with 0.4mg EB, and no 
reduction in fertility in the non-responsive line dosed with control (Figs. 15-16) N 
= 5-8 litters/treatment group. Based on these results, our hypothesis was not 
supported. There is no evidence that responsive females are more sensitive to 
suppression by EB than nonresponsive females. 
 Endocrine disrupting chemicals can have effects on the development of 
female reproductive physiology (Diamanti-Kandarakis et al. 2009). Examples of 
decreased fertility or reproductive tract abnormalities have been seen in 
invertebrates, reptiles, birds, mammals and humans that have been exposed to 
exogenous chemicals during both development and adulthood (Sharara, Seifer, 
and Flaws 1998). Diethylstilbestrol, a synthetic estrogen that was prescribed to 
pregnant women to reduce the risk of loss of the fetus, was found to increase the 
risk of reproductive tract abnormalities and cancers in both sons and daughters 
that were exposed in utero (Giusti, Iwamoto, and Hatch 1995). Neonatal 
exposure to genistein, a phytoestrogen, was shown to cause disruption to 
ovarian function, estrous cycling, and overall fertility in mice (Jefferson, Padilla-
Banks, and Newbold 2007).  
  Studying the effect of estrogenic compounds in prenatal and neonatal 
female rodents is complicated by the presence of alpha-fetoprotein. Alpha-
fetoprotein is a glycoprotein that binds estradiol in rodent fetuses to prevent 
masculinization of the developing female brain (Bakker et al. 2006).  Compounds 
with high affinity to alpha-fetoprotein, including estradiol benzoate, are 
inactivated at low and moderate doses, but compounds that are weakly bound 
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may still be able to affect the developing brain (Vandenberg et al. 2012). This 
difficulty can make it difficult to assess if a specific compound and dose will be 
disruptive in females.  
 This study was unable to demonstrate any effect of estradiol benzoate on 
the responsive and nonresponsive lines. We cannot be certain we tested our 
original hypothesis: that responsive female mice will be more sensitive to an 
environmental stressor such as estradiol benzoate during a critical 
developmental period than nonresponsive female mice. This does not mean that 
a different compound, dose, dosing schedules or method would have similar 
negative results. Difficulties associated with studying endogenous chemicals and 
hormones in female subjects due to alpha-fetoprotein in developing rodents and 
shifting hormonal states due to estrous and menstrual cycles in adults will require 
more complicated experimental design.  
  
Summary 
Endocrine disrupting compounds have the potential to act differentially on 
mammals from varying genetic backgrounds. Our results suggest that genetic 
variation in reproductive sensitivity to winter-like photoperiods may not cause 
differences in response to an entirely different environmental factor, endocrine 
disruption using the chemicals tested in these experiments. Genetic differences 
in susceptibility to EDCs may exist separately from genetic variation in 
susceptibility to the effects of short photoperiod. If so, then our artificial selection 
lines could not reveal or detect such variation in sensitivity to EDCs.  
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Future Directions 
 This study cannot rule out our hypothesis that variation in sensitivity to 
short photoperiod also results in variation in response to EDCs and other 
environmental factors that might alter fertility. Different timing, EDCs, and doses 
might be necessary. In each case, a pilot dose response study should establish 
an effective dose, followed by a comparison of the R and NR selection lines. The 
study of the effects of endocrine disrupting chemicals on fertility and reproduction 
can be divided into prenatal, neonatal, and adult studies. Various classes of 
chemicals taken from known EDCs (Vandenberg et al. 2013) should be tested at 
all three of these stages to determine the developmental risk. These studies can 
be done using an organ as a proxy for fertility, such as testes and ovaries as 
used in our study, or can also be accomplished through other measurements. 
Fertility can also be measured by breeding exposed and non-exposed animals to 
look at success of fertilization and maturation of offspring. Hormonal assays can 
also be performed to assess the effects of EDCs on luteinizing hormone, 
estrogen, or testosterone at various stages in both males and females.  
In studies specifically measuring the individual variation in response to 
exposure, genetic assays may give some indication of key areas in the genome 
that may offer more resiliency in some individuals. For example, sequencing 
studies of the R and NR lines might reveal differences in the number of plasma 
proteins that transport EDCs, in sequence or expression of receptors that bind 
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EDCs, or of enzymes that metabolize EDCs. Any of these could underlie genetic 
variation in response to EDCs.  
New selection lines of mice could be made by trapping mice from an area 
that has been contaminated with EDCs. The mice would then have testes 
measured with calipers and ovaries and uteri measured via laparoscopy (Paul D. 
Heideman et al. 1999) to select for mice that have a reproductive response to 
chemical exposure. These EDC selection lines would provide a direct test for 
heritable variation in response to endocrine disruptors.  
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http://www.scienceminusdetails.com/2011/11/shape-science-or-dr-licorice-
explains.html 
Figure 1. Structure of BPA compared to estradiol. The regions highlighted in blue 
interact most strongly with estrogen receptors. 
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Figure 2a. Endocrine disrupting chemicals (EDCs) can have agonistic or antagonistic 
effects on multiple levels of the hypothalamic-pituitary-gonadal (HPG) axis. These effects 
can happen at the level of the neuron (kisspeptin-KISS; gonadotropin inhibiting 
hormone-GnIH; gonadotropin releasing hormone-GnRH),  hormone (lutenizing hormone-
LH; follicle-stimulating hormone-FSH), or secondary sex characteristics. 
Figure 2b. Representation 
of an average number of 
gonadotropin releasing 
hormone (GnRH) neurons 
in an average mouse. With 
adequate food, melatonin 
(long day-LD photoperiod), 
and an absence of 
disease/parasites the 
output of GnRH pulses will 
result in fertility 
 28
 
 
 
 
Figure 2d. Representation of a 
mouse with 60% of average 
number of gonadotropin 
releasing hormone (GnRH) 
neurons under moderately 
inhibitory conditions. Decreased 
levels of melatonin due to a 
short-day (SD) photoperiod, 
combined with disease or 
parasites will result in a 
decreased secretion of GnRH. 
This reduction is enough to bring 
GnRH below threshold, so the 
mouse becomes infertile. A 
hypothesis in this thesis is that 
endocrine disrupting chemicals 
(EDCs) are another input that 
could be inhibitory or excitatory. 
 
Figure 2c. Representation of an 
average number of gonadotropin 
releasing hormone (GnRH) 
neurons in a mouse under 
moderately inhibitory conditions. 
Decreased levels of melatonin 
due to a short-day (SD) 
photoperiod, combined with 
disease or parasites will result in a 
decreased secretion of GnRH. 
This reduction is not enough to 
bring GnRH below threshold, so 
the mouse is still fertile. 
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Figure 3. Levels of luteinizing hormone (LH) in adult male mice in a responsive 
line (R) and a nonresponsive line (NR) dosed with bisphenol-a (BPA). No 
significant difference was found (see results). N = 7/treatment group (Mean +/- 
SEM). 
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Figure 4. Testes mass in adult male mice in a responsive line (R) and a 
nonresponsive line (NR) dosed with bisphenol-a (BPA). There was a significant 
difference between the R and NR lines, but no difference between doses or line 
crossed with dose (see results). N = 7/treatment group (Mean +/- SEM). 
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Figure 5. Seminal vesicle mass in adult male mice in a responsive line (R) and a 
nonresponsive line (NR) dosed with bisphenol-a (BPA). There was a significant 
difference between the R and NR lines, but no difference between doses or line 
crossed with dose (See Results). N = 7/treatment group (Mean +/- SEM).  
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Figure 6: IR-GnRH neuron counts in adult male mice in a responsive (R) and non 
responsive (NR) line after BPA dosing. No signficant difference found between 
line, doses, or line crossed with dose (see results). N = 5-7/treatment group 
(Mean +/- SEM). 
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Figure 7: Testes Weights after testosterone propionate (TP) dose in long 
photoperiod. There was a significant difference between responsive (R) and 
nonresponsive (NR) lines, as well as between control and TP dose (see results). 
No significant difference of line crossed with treatment. N = 3-4 litters/treatment 
group (Mean +/- SEM). 
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Figure 8: Effects of selection line (responsive: R; nonresponsive: NR) on seminal 
vesicle (SV) mass in a long photoperiod. There was a significant difference 
between lines and between doses, but no significant effect of line crossed with 
dose (see results). N = 3-4 litters/treatment group (mean +/- SEM). 
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Figure 9: Effects of selection line (responsive: R; nonresponsive: NR) on testes 
mass in a short photoperiod (see results). There was a significant difference 
between the responsive and nonresponsive lines. There was no significant 
difference between the control dose and the testosterone propionate (TP) 
treatment and no significant difference for line crossed with treatment. N = 7-8 
litters/treatment group (Mean +/- SEM). 
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Figure 10: Effects of selection line (responsive: R; nonresponsive: NR) on 
seminal vesicle (SV) mass in a short photoperiod (see results). There was a 
significant difference between lines, but not between doses or in line crossed 
with dose. N = 7-8 litters/treatment group (Mean +/- SEM). 
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Fig 11: Testes Weights after higher testosterone propionate (TP) dose in short 
photoperiod (see results). There was a significant difference between lines, but 
not between doses or between line crossed with dose. N = 8 litters/treatment 
(Mean +/- SEM). 
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Fig 12: Seminal vesicle weights after higher testosterone 
propionate (TP) dose in short photoperiod (see results). There was 
a significant difference between lines, but not between doses or 
between line crossed with dose. N = 8 litters/treatment (Mean +/- 
SEM). 
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Fig 13: Seminal vesicle weights comparing testosterone 
propionate (TP) treatments from experiments 2a (old TP) and 2b 
(new TP). Significant difference between all three treatments. 
N=7-15 litters/treatment group (mean +/- SEM). 
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treatments from experiments 2a (old TP) and 2b (new TP).. 
Significant difference between oil and new testosterone 
propionate (TP). No difference between old TP and new TP or 
between oil and old TP. N = 7-15/treatment group (mean+/- 
SEM) litters. 
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Fig 15: Ovary weights after estradiol benzoate (EB) in long 
photoperiod (see results). There was no significant difference 
between lines or doses. N = 5-8 litters/treatment (Mean +/- 
SEM). 
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Fig 15: Uterine weights after estradiol benzoate (EB) in long 
photoperiod (see results). There was no significant difference 
between lines or doses. N = 5-8 litters/treatment (Mean +/- 
SEM). 
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